Kyoto, Japan

Hirohito Tsubouchi

This inventor holds 1 USPTO granted patent. Top assignee: Kyoto University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirohito Tsubouchi. Retrieved from https://idiyas.com/inventor/hirohito-tsubouchi-oustztpx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hirohito Tsubouchi: Innovator in Hepatic Therapeutics

Introduction

Hirohito Tsubouchi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. His innovative work has led to the development of a therapeutic agent that addresses acute liver failure.

Latest Patents

Tsubouchi holds a patent for an "Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof." This invention provides a therapeutic agent for acute liver failure that contains a hepatocyte growth factor (HGF). It is particularly aimed at treating fulminant hepatitis or late-onset hepatic failure. The invention also includes a method for evaluating the efficacy of HGF by measuring biomarkers in samples from liver injury patients.

Career Highlights

Hirohito Tsubouchi is affiliated with Kyoto University, where he conducts research and develops innovative solutions for liver-related health issues. His work has garnered attention for its potential to improve patient outcomes in cases of acute liver failure.

Collaborations

Tsubouchi has collaborated with notable colleagues, including Akio Ido and Akira Shimizu. Their combined expertise has contributed to advancements in the understanding and treatment of hepatic conditions.

Conclusion

Hirohito Tsubouchi's contributions to the field of hepatic therapeutics highlight the importance of innovation in medicine. His work continues to pave the way for new treatments that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…